Drug Profile
Research programme: fibrosis therapeutics - Galapagos
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Galapagos NV
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Fibrosis